title: Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin.
abstract: Angiogenesis is a characteristic feature of many aggressive tumours and other disorders. Antibodies capable of binding to new blood vessels, but not to mature vessels, could be used as selective targeting agents for immunoscintigraphic and radioimmunotherapeutic applications. Here we show that scFv(L19), a recombinant human antibody fragment with sub-nanomolar affinity for the ED-B domain of fibronectin, a marker of angiogenesis, can be stably labelled with iodine-125 and astatine-211 with full retention of immunoreactivity, using a trimethyl-stannyl benzoate bifunctional derivative. Biodistribution studies in mice bearing two different types of tumour grafted subcutaneously, followed by ex vivo micro-autoradiographic analysis, revealed that scFv(L19) rapidly localises around tumour blood vessels, but not around normal vessels. Four hours after intravenous injection of the stably radioiodinated scFv(L19), tumour to blood ratios were 6:1 in mice bearing the F9 murine teratocarcinoma and 9:1 in mice bearing an FE8 rat sarcoma. As expected, all other organs (including kidney) contained significantly less radioactivity than the tumour. Since the ED-B domain of fibronectin has an identical sequence in mouse and man, scFv(L19) is a pan-species antibody and the results presented here suggest clinical utility of radiolabelled scFv(L19) for the scintigraphic detection of angiogenesis in vivo. Furthermore, it should now be possible to investigate scFv(L19) for the selective delivery of 211At to the tumour neovasculature, causing the selective death of tumour endothelial cells and tumour collapse.
authors.affiliation: Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Building 36 M14, Winterthurerstrasse 190, 8057 Zürich, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Demartis
authors.forename: L
authors.initials: L
authors.lastname: Tarli
authors.forename: L
authors.initials: L
authors.lastname: Borsi
authors.forename: L
authors.initials: L
authors.lastname: Zardi
authors.forename: D
authors.initials: D
authors.lastname: Neri
mesh_terms: D000818:Animals; D001246:Astatine; D001565:Benzoates; D005353:Fibronectins / Q000276:immunology*; D007128:Immunoglobulin Fragments; D007457:Iodine Radioisotopes; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000098:blood supply* / Q000000981:diagnostic imaging*; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012039:Regional Blood Flow / Q000502:physiology; D014018:Tissue Distribution; D014298:Trimethyltin Compounds
chemical_list: D001565:Benzoates; D005353:Fibronectins; D007128:Immunoglobulin Fragments; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D014298:Trimethyltin Compounds; C061345:N-succinimidyl 3-(trimethylstannyl)benzoate; D001246:Astatine